These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
62 related articles for article (PubMed ID: 607217)
1. [Biotransformation of 2-phenyl-4-/beta-dimethylamino-ethyl/-6-methyl-2,3-dihydro-1,4-benzoxazine-3-one ("AR 17 O48) a potential antirheumatic agent]. Pfeifer S; Bornschein I; Gehrke A Pharmazie; 1977 Oct; 32(10):587-92. PubMed ID: 607217 [No Abstract] [Full Text] [Related]
2. Seclazone: biotransformation during absorption in the rat, binding in plasma, and disappearance from plasma in the dog. Edelson J; Douglas JF; Ludwig BJ Drug Metab Dispos; 1973; 1(6):737-41. PubMed ID: 4156294 [No Abstract] [Full Text] [Related]
3. [Mass spectrometry of 2-phenyl-4-[beta-dimethylaminoethyl]-6-methyl-2,3-dihydro-1,4-benzoxazine-3-one ("AR 17,048") and its metabolites]. Bornschein I; Gehrke A; Pfeifer S; Kraft R Pharmazie; 1977 Nov; 32(11):695-7. PubMed ID: 609589 [No Abstract] [Full Text] [Related]
4. The metabolic fate of seclazone in man. Edelson J; Schuster E; Shahinian S; Douglas JF Arch Int Pharmacodyn Ther; 1974 May; 209(1):66-74. PubMed ID: 4416360 [No Abstract] [Full Text] [Related]
5. [Biological behavior: serum levels, excretion and biotransformation of (3-benzoylphenyl)-2-propionic acid, or ketoprofen, in animals and men]. Populaire P; Terlain B; Pascal S; Decouvelaere B; Renard A; Thomas JP Ann Pharm Fr; 1973 Dec; 31(12):735-49. PubMed ID: 4804224 [No Abstract] [Full Text] [Related]
6. Radioisotopic and synthetic studies related to caroxazone metabolism in man. Bernardi L; Coda S; Nicolella V; Vicario GP; Gioia B; Minghetti A; Vigevani A; Arcamone F Arzneimittelforschung; 1979; 29(9):1412-6. PubMed ID: 583252 [TBL] [Abstract][Full Text] [Related]
7. [Activity of the antirheumatic benzofenac VUFB, in experimental animals and man, in relation to the species specificity of pharmacokinetics and biotransformation]. Grimová J; Roubal Z; Koruna I; Nĕmecek O Cas Lek Cesk; 1982 Sep; 121(34-35):1078-82. PubMed ID: 7127389 [No Abstract] [Full Text] [Related]
8. Metabolic fate of the new Ca++-channel blocking agent (+)-(2S,3S)-3-acetoxy-8-chloro-(2-(dimethylamino)ethyl)-2,3-dihydro- 2-(4-methoxyphenyl)-2,5-benzothiazepin-4-(5H)-one maleate. Distribution, excretion and protein binding in rats and dogs. Nakamura S; Ohashi M; Suzuki T; Sugawara Y; Usuki S; Takaiti O Arzneimittelforschung; 1989 Sep; 39(9):1100-8. PubMed ID: 2590259 [TBL] [Abstract][Full Text] [Related]
9. LD50 value, phototoxicity and convulsion induction test of the new quinolone antibacterial agent (S)-10-[(S)-(8-amino-6-azaspiro[3,4]octan-6-yl)]-9-fluoro-2, 3-dihydro-3-methyl-7-oxo-7H-pyrido[1,2,3-de][1,4]benzoxazine-6-carboxyl ic acid hemihydrate in laboratory animals. Shimoda K; Akahane K; Nomura M; Kato M Arzneimittelforschung; 1996 Jun; 46(6):625-8. PubMed ID: 8767355 [TBL] [Abstract][Full Text] [Related]
10. Physiologic disposition and metabolic fate of a new anti-inflammatory agent, cis-5-fluro-2-methyl-1-(p-(methylsulfinyl)-benzylidenyl)-indene-3-acetic acid in the rat, dog, rhesus monkey, and man. Hucker HB; Stauffer SC; White SD; Rhodes RE; Arison BH; Umbenhauer ER; Bower RJ; McMahon FG Drug Metab Dispos; 1973; 1(6):721-36. PubMed ID: 4156293 [No Abstract] [Full Text] [Related]
11. Isolation and identification of metabolites of ofloxacin in rats, dogs and monkeys. Sudo K; Okazaki O; Tsumura M; Tachizawa H Xenobiotica; 1986 Aug; 16(8):725-32. PubMed ID: 3464137 [TBL] [Abstract][Full Text] [Related]
12. Antirheumatic agents: novel methotrexate derivatives bearing a benzoxazine or benzothiazine moiety. Matsuoka H; Ohi N; Mihara M; Suzuki H; Miyamoto K; Maruyama N; Tsuji K; Kato N; Akimoto T; Takeda Y; Yano K; Kuroki T J Med Chem; 1997 Jan; 40(1):105-11. PubMed ID: 9016334 [TBL] [Abstract][Full Text] [Related]
13. [Parsalmide: a new anti-inflammatory agent. V. Pharmacokinetic and metabolic aspects in the rabbit]. Fleischmann L; Lavezzo A; Colombo L Boll Chim Farm; 1976 Feb; 115(2):175-82. PubMed ID: 949359 [No Abstract] [Full Text] [Related]
14. Metabolism of 4-(3-(dimethylamino)propyl)-3,4-dihydro-2-(1-hydroxyethyl)-3-phenyl-2H-1,4-benzothiazine (SQ 11,579) under in vitro and in vivo conditions by rats, dogs, and monkey. Lan SJ; Chando TJ; Cohen AI; Weliky I; Schreiber EC Drug Metab Dispos; 1973; 1(4):619-27. PubMed ID: 4149635 [No Abstract] [Full Text] [Related]
15. [Interaction problems in the therapy with steroid-free anti-rheumatics]. Husmann F Fortschr Med; 1981 Aug; 99(31-32):1231-5. PubMed ID: 7274937 [TBL] [Abstract][Full Text] [Related]
16. [Absorption and organ distribution of the new antidepressant azaphen]. Siniukhin VN Farmakol Toksikol; 1973; 26(4):409-11. PubMed ID: 4789881 [No Abstract] [Full Text] [Related]
17. Effect of oral administration of clinically relevant doses of dexamethasone on regulation of cytochrome P450 subfamilies in hepatic microsomes from dogs and rats. Zhang K; Kuroha M; Shibata Y; Kokue E; Shimoda M Am J Vet Res; 2006 Feb; 67(2):329-34. PubMed ID: 16454641 [TBL] [Abstract][Full Text] [Related]
18. [Absorption of af 2071 (hydrocortisone-bendazac ester) after topical application compared with oral administration]. Catanese B; Barillari G; Rossi V Boll Chim Farm; 1978 Jun; 117(6):368-74. PubMed ID: 743382 [No Abstract] [Full Text] [Related]
19. Identification of the biologically active form of sulindac. Duggan DE; Hooke KF; Risley EA; Shen TY; Arman CG J Pharmacol Exp Ther; 1977 Apr; 201(1):8-13. PubMed ID: 850147 [TBL] [Abstract][Full Text] [Related]
20. Metabolic fate of the anti-inflammatory agent alpha-(4-(1-oxo-2-isoindolinyl)-phenyl)-propionic acid (K 4277) in the rhesus monkey. Chasseaud LF; Fry BJ; Valzelli G; Tosolini GP Arzneimittelforschung; 1974 Oct; 24(10):1606-9. PubMed ID: 4479769 [No Abstract] [Full Text] [Related] [Next] [New Search]